View Press Releases

Huateng Pharma Introduces Semaglutide Side Chain

February 22, 2024

Huateng Pharma, a leading provider of high-quality pharmaceutical intermediates, is proud to unveil its latest breakthrough product: Semaglutide Side Chain. This innovative addition to Huateng Pharma's portfolio represents a significant milestone in pharmaceutical innovation, offering a range of compounds including AEEA-AEEA (CAS NO.: 1143516-05-5), SNAC (CAS NO.: 203787-91-1), tBuO-Ste-Glu(AEEA-AEEA)-OtBu (CAS NO.:1118767-16-0), and Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH (CAS NO.: 1662688-20-1).

Semaglutide Side Chain is a critical component in the synthesis of semaglutide, a groundbreaking medication used in the treatment of type 2 diabetes. Huateng Pharma's dedication to excellence and innovation is evident in the meticulous development and production of these essential compounds, ensuring the highest quality and purity standards.

AEEA-AEEA (CAS NO.: 1143516-05-5) and SNAC (CAS NO.: 203787-91-1) are key intermediates in the synthesis of Semaglutide Side Chain, playing crucial roles in the manufacturing process. Additionally, tBuO-Ste-Glu(AEEA-AEEA)-OtBu (CAS NO.:1118767-16-0) and Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH (CAS NO.: 1662688-20-1) contribute to the structural integrity and efficacy of the final product.

Ms. Sonia Lee, Sales Director at Huateng Pharma, expressed his excitement about the launch of Semaglutide Side Chain. "We are thrilled to introduce Semaglutide Side Chain to the pharmaceutical market. This innovative product underscores Huateng Pharma's commitment to advancing healthcare through cutting-edge solutions. With our expertise in intermediate development, we are proud to play a significant role in the production of semaglutide, a medication that has the potential to improve the lives of millions of people living with type 2 diabetes."

Huateng Pharma's dedication to quality assurance and regulatory compliance ensures that Semaglutide Side Chain meets the rigorous standards set forth by regulatory authorities worldwide. The company's state-of-the-art manufacturing facilities and stringent quality control processes guarantee the reliability and consistency of its products.

For more information about Huateng Pharma's Semaglutide Side Chain and other innovative pharmaceutical solutions, please contact

About Huateng Pharma

Huateng Pharma is a leading provider of high-quality Pharmaceutical intermediates, specializing in the synthesis of innovative compounds for the pharmaceutical industry. With a focus on excellence and innovation, Huateng Pharma is committed to advancing healthcare through cutting-edge solutions.